ARA 290 vs Wolverine Stack
ARA 290 and Wolverine Stack are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: ARA 290 is 11-amino-acid epo-derived linear peptide, while Wolverine Stack is two-component repair blend — bpc-157 (10 mg) + tb-500 (10 mg) in one 20 mg vial — different molecular classes with different handling consequences; their leading degradation routes differ (asparagine/glutamine deamidation is the most plausible slow route for this sequence. for ARA 290, methionine oxidation of the tb-500 component, accelerated by light and trapped air for Wolverine Stack), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
ARA 290 — origin
ARA 290 (Cibinetide) is an 11-residue peptide modelled on the helix-B surface of erythropoietin. It was engineered to engage the innate repair receptor — a heteromer of the EPO receptor and the beta-common receptor — without the erythropoietic (red-blood-cell-stimulating) activity of full-length EPO.
Wolverine Stack — origin
The Wolverine Stack combines the two most-studied tissue-repair peptides in a single 20 mg vial: BPC-157 (10 mg) and TB-500 (10 mg). It inherits the handling profile of both — the forgiving, gastric-derived BPC-157 and the oxidation-sensitive Thymosin-Beta-4 fragment TB-500 — so the blend is handled to the stricter of the two.
ARA 290 research themes
Studied for selective engagement of the EPOR/beta-common receptor heteromer that mediates tissue-protective signalling, distinct from the classical erythropoietic receptor.
A substantial share of the published literature examines small-fibre and neuropathic-pain research models.
Investigated for modulation of inflammatory pathways in preclinical tissue-injury models.
Wolverine Stack research themes
BPC-157 is studied around angiogenesis and growth-factor signalling; TB-500 around actin-mediated cell migration — non-overlapping routes into tissue repair.
Studied together in connective-tissue and wound-healing research designs where both mechanisms are of interest.
Because their mechanisms do not overlap, the two are frequently examined in parallel rather than as substitutes for one another.
ARA 290 handling
- Reach room temperature before opening the vial.
- Add diluent gently down the vial wall; do not vortex.
- Use low-bind labware at low working concentrations to limit adsorption.
Wolverine Stack handling
- Reach room temperature before opening; the cake is hygroscopic.
- Add diluent gently down the wall and swirl; do not shake or vortex.
- Keep out of light and portion early, since every opening exposes the oxidation-sensitive TB-500 component to fresh air.
Both third-party tested
Every Popular Peptides batch of ARA 290 and Wolverine Stack is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
ARA 290 reference
Related comparisons
ARA 290 and Wolverine Stack are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.